Baldanza also dismissed surveys that found Spirit lacking in customer service when compared to other airlines. He said many surveys focus on the business traveler, which is not Spirit's core audience. He said the company's target market is very pleased that Spirit's prices, even with a few extras, are still lower than many other alternatives.
Cramer said Spirit remains one of his favorite airline plays.
Back to ASCO
It's that time of year again: Time for the American Society of Clinical Oncology's annual conference, which begins on May 31. Why should you care if you're not a doctor? Cramer said in today's market, investors need a catalyst, and those companies presenting at this year's conference should see their stocks pop on this year's news.
Cramer said most of this year's presenters are already long-time favorites and are investments with long shelf lives. But that doesn't mean shares can't spike higher after they announce their latest findings. That's certainly the case with Gilead Sciences (GILD), he said. The company already has an excellent HIV franchise and Hepatitis C prospects, but Gilead is also pushing into cancer drugs with one now in Phase III testing. Cramer said it could be a needle-mover for the company.Also presenting this year is Bristol-Myers Squibb (BMY), which is developing cancer drugs that would be a $5 billion to $6 billion opportunity for the company. Bristol also sports a 3.2% yield while investors wait for those efforts to bear fruit. Other favorites included Merck (MRK), which Cramer owns for his charitable trust,
Lightning RoundIn the Lightning Round, Cramer was bullish on Asbury Automotive Group (ABG), Radian Group (RDN), Genworth Financial (GNW), Penn National Gaming (PENN), Carmax (KMX), LinnCo (LNCO), Dominion Resources (D) and Cheniere Energy (LNG). Cramer was bearish on MGIC Investment (MTG) and ALPS Alerian MLP ETF (AMLP).
Executive Decision: Scott PetersIn his second "Executive Decision" segment, Cramer spoke with Scott Peters, president, chairman and CEO of Healthcare Trust of America, a REIT that specializes in medical office buildings and currently yields 4.4%. Peters said that perhaps the biggest driver for his company's growth will be the implementation of President Obama's Affordable Care Act, which takes effect in 2014. He said that with tens of millions more people with insurance, the need for outpatient services from primary care on up will be considerably greater. Peters also spoke of increased employment as another driver of growth in health care, as more jobs also equals more people with insurance. Given these big drivers, why did Healthcare Trust report a sluggish quarter with weaker-than-expected occupancy rates? Peters explained the Affordable Care Act has created many questions in the industry for the past few years, and those questions have led to a lot of uncertainty. But now that the deadline looms larger, many providers are beginning to make their expansion plans. Peters noted that larger office spaces have been the hottest commodity of late and rents are likely to increase between 3% and 4% next year. Cramer once again told investors that those looking for good yields need to consider REITs like Healthcare Trust.
No Huddle OffenseIn his "No Huddle Offense" segment, Cramer said he's still not willing to recommend Tesla Motors (TSLA - Get Report), the stock, even though Tesla the product seems to be red-hot with consumers everywhere. Cramer said he understands the arguments that outside of Wall Street, which still loathes the company, Tesla is gaining traction in both sales and mindshare. He also offered a tip of the hat to CEO Elon Musk for beating back the naysayers time after time. That said, Cramer attributed much of Tesla's recent spike to the fact that there simply isn't a lot of stock available for the shorts to get. With shares in tight supply, Cramer said he still can't opine on the stock, even though the cars are proving to be a big success for the next generation of investors. To watch replays of Cramer's video segments, visit the Mad Money page on CNBC. -- Written by Scott Rutt in Washington, D.C. To email Scott about this article, click here: Scott Rutt Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts